Whatever the level of contribution of these signalling pathways in RAS-induced melanoma, our results demonstrate that the RAF/MEK/ERK pathway is absolutely required downstream of NRASQ61K from initiation to tumour maintenance. The gene discussed is MAP2K7; the disease is neoplasm.